Stem Cell Recruitment Therapy® is safe and effective, helping the body boost its ability to heal itself. It is
administered through a single injection of Human Amniotic Fluid (AF).
Amniotic Fluid is acellular and contains a rich mixture of collagens, cytokines, elastins and growth factors
that creates an extra-cellular matrix which supports healing and has the potential to reduce scarring and
inflammation. AF is filled with growth factors which assist the body in tissue repair, reducing pain and
inflammation and contributing to the regeneration and reconstruction of injured tissue.
Amniotic Fluid takes advantage of the body’s ability to repair itself. With an amniotic fluid injection, your
physician injects the amniotic fluid from donated amniotic tissue into your body. The amniotic fluid limits
the expression of inflammatory cytokines and contains large amounts of hyaluronic acid that entrap
inflammatory cells. Amniotic fluid goes far beyond the benefits of standard “injection therapy."
While cortisone and other drugs only provide temporary pain relief, amniotic fluid helps modulate healing
by promoting reconstruction rather than scar tissue formation. The growth factors in the amniotic fluid may
recruit your body’s own stem cells, directly mitigating the repair and regeneration of healthy tissue.
Additionally, amniotic fluid injections contain hyaluronic acid, helping to lubricate joints and tendons,
easing the pain and helping restore mobility.
Yes, amniotic fluid injections are covered by insurances. Consult your physician to see if you are covered.
Stem Cell Recruitment Therapy®, Stem Cell Recruitment™(SCR), Stem Cell Recruitment Therapy™(SCRT), Stem Cell Recruitment Facial™, Stem Cell Recruitment Ocular™, DermaFlo™, OrthoFactor™ and Vivaderm™ are trademarks of Russell Health, Inc. The treatments described on this marketing are not considered to be standard of care for any condition or disease. The treatments described on this marketing are not considered to be standard of care for any condition or disease. SCR, SCRT, SCR Facial, DermaFlo, OrthoFactor and Vivaderm™ attempt to utilize acellular, minimally manipulated tissue allografts and are comprised of tissue allograft components intended for homologous use to supplement tissue. Stem Cell Recruitment Therapy™ products are classified by the Food and Drug Administration (FDA) as Human Cell, Tissue and Cellular and Tissue-Based Products (HCT/P) that are regulated solely under section 361 of the Public Health Service (PHS) Act. FDA recognizes that human tissue was designed, or evolved, to perform certain functions in the human body with exquisite safety and effectiveness. As an HCT/P regulated solely under Section 361 of the PHS Act, Russell Health’s Stem Cell Recruitment Therapy™ products are exempt from FDA pre-market review, clearance, and approval from FDA. Please consult your doctor to see if an amniotic fluid injection is right for you. No medical advice has been offered herein. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Results may vary.